Keywords
Rheumatology
Exocrine glands
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the characteristics of Sjögren's Syndrome (SS). Bibliographic review: Sjögren's syndrome is a chronic autoimmune disease of the connective tissue, which involves exocrine glands and can be divided into primary and secondary. The triad of clinical symptoms includes symptoms of dryness, fatigue and pain. As a systemic disease, SS can involve virtually any organ system, leading to extremely pleomorphic clinical manifestations. The incidence rate of SS is 6.92 per 100,000 people per year. Regarding the impact of SS on quality of life, the disease negatively affects the patient's daily activity due to the high prevalence of fatigue, depression, anxiety and decreased physical performance. Final considerations: SS is an autoimmune disease whose main symptoms are: keratoconjunctivitis sicca and xerostomia. In addition, it can have multiple involvements at the systemic level. There is no single test for its diagnosis and it should be suspected in patients with persistent symptoms of dryness, enlargement of the parotid gland in addition to an unexplained increase in dental caries. Treatment is with symptoms in cases without systemic involvement and those affected systemically are treated with immunosuppression.
References
ANDRÉ F e BOCKLE BC. Sjögren's syndrome. J Dtsch Dermatol Ges, 2022; 20(7): 980-1002.
AIYEGBUSI O, et al. Renal Disease in Primary Sjögren's Syndrome. Rheumat Ther, 2021; 8(1): 63-80.
ATZENI F, et al. Cardiovascular Involvement in Sjögren's Syndrome. Front Immunol, 2022; 13: 879516.
BJORDAL O, et al. Primary Sjögren's syndrome and the eye. Surv Ophthalmol, 2020; 65(2): 119-132.
CAFARO G, et al. One year in review 2021: Sjögren's syndrome. Clin Exp Rheuma, 2021; 39(6): 3-13.
CHEN YH, et al. Rituximab Therapy for Primary Sjögren's Syndrome. Front Pharmacol, 2021; 12: 731122.
DAI M, et al. Clinical Features and Laboratory Examination Results of Sjogren's Syndrome Complicated with Thyroid Disorders: A Retrospective Analysis. J Healthc Eng, 2021; 2021: 2280070.
DU W, et al. The Multiple Roles of B Cells in the Pathogenesis of Sjögren's Syndrome. Front Immunol, 2021; 12: 684999.
JENSEN MLN, et al. Sjögren's syndrome. Ugeskr Laeger, 2021; 183(31): V04210309.
JUNG JY, et al. Salivary Biomarkers in Patients with Sjögren's Syndrome-A Systematic Review. Int J Mol Sci, 2021; 22(23): 12903.
KAUR H, et al. Increased Threat of Thyroid Diseases in Patients with Sjogren's Syndrome: A Systematic Review. Cureus, 2022; 14(8): e28062.
KIM J, et al. Metformin as a Treatment Strategy for Sjögren's Syndrome. Int J Mol Sci, 2021; 22(13): 7231.
LEE AS, et al. Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren's. Chest, 2021; 159(2): 683-698.
LUPPI F, et al. Interstitial lung disease in Sjögren's syndrome: a clinical review. Clin Exp Rheumatol, 2020; 38(4): 291-300.
MAELAND E, et al. Understanding Fatigue in Sjögren's Syndrome: Outcome Measures, Biomarkers and Possible Interventions. Front Immunol, 2021; 12: 703079.
MANFRÈ V, et al. Sjögren's syndrome: one year in review 2022. Clin Rhe, 2022; 40(12): 2211-2224.
MANFRÈ V, et al. One year in review 2020: comorbidities, diagnosis and treatment of primary Sjögren's syndrome. Clin Exp Rheumatol, 2020; 38(4): 10-22.
MAVAGRANI CP e MOUTSOPOULOS HM. Sjögren's syndrome: Old and new therapeutic targets. J Autoimmun, 2020; 110: 102364.
NEGRINI S, et al. Sjögren's syndrome: a systemic autoimmune disease. Clin Med, 2022; 22(1): 9-25.
OKAWA Y e IHARA K. Sensorineural Hearing Loss in Sjögren's Syndrome. Int J Mol Sci, 2022; 23(19): 11181.
SARRAND J, et al. The Involvement of Alarmins in the Pathogenesis of Sjögren's Syndrome. Int J Mol Sci, 2022; 23(10): 5671.
SEELIGER T, et al. Neuro-Sjögren: Peripheral Neuropathy With Limb Weakness in Sjögren's Syndrome. Front Immunol, 2019; 10: 1600.
THALAYASINGAM N, et al. New developments in Sjogren's syndrome. Rheumatology (Oxford), 2021; 60(6): 53-61.
TIAN Y, et al. Advances in Pathogenesis of Sjögren's Syndrome. J Immunol Res, 2021; 2021: 5928232.
ZHAN Q, et al. Pathogenesis and treatment of Sjogren's syndrome: Review and update. Front Immunol, 2023; 14: 1127417.